AI Model Claude Fails to Invent Scorpion Antivenom in Research Trial
Audio narration · Coming soon
An investment research firm collaborated with Anthropic to test whether an unreleased version of the AI model Claude could develop scorpion antivenom. While the AI generated some promising initial ideas, experts confirmed it did not produce a viable drug. This experiment highlights current limitations of AI in drug development.
Why this matters
PRISM scored this story 55/100 for interest.
Originally published by theverge